2012

Financial Report

Annual Accounts of year end 31 December 2012 (only available in french)

Annual Accounts of year end 31 December 2012 (only available in french)

2013

Financial Report

AR 2013 Annual Report

AR 2013 Annual Report

H1 2013 Interim Financial Report

H1 2013 Interim Financial Report

2014

Financial Report

2014 Annual Report

2014 Annual Report

Q3 2014 Business Update

Q3 2014 Business Update

H1 2014 Interim Financial Report

H1 2014 Interim Financial Report

Q1 2014 Business Update

Q1 2014 Business Update

2015

Financial Report

AR 2015 Annual report

AR 2015 Annual report

Q3 2015 Business Update

Q3 2015 Business Update

H1 2015 Interim Financial Report

H1 2015 Interim Financial Report

Q1 2015 Business Update

Q1 2015 Business Update

2016

Financial Report

Q1 2016 Business Update

Q1 2016 Business Update

Celyad 2016 First Half Year Report

Celyad 2016 First Half Year Report

Q3 2016 Business Update

Q3 2016 Business Update

2017

Financial Report

First Half 2017 Financial statements and operational progress

First Half 2017 Financial statements and operational progress

First Quarter 2017 Business Update

First Quarter 2017 Business Update

Celyad Reports 2016 Financial and Operating Results

Celyad Reports 2016 Financial and Operating Results

Celyad's Annual Report 2016

Celyad's Annual Report 2016

2018

Financial Report

Celyad Reports 2017 Financial and Operating Results and Expected Key Milestones for 2018

Celyad Reports 2017 Financial and Operating Results and Expected Key Milestones for 2018

Annual report 2017

Annual report 2017

Regulated information

Celyad Appoints Filippo Petti as Chief Financial Officer

Celyad Appoints Filippo Petti as Chief Financial Officer

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee

Celyad Announces FDA Acceptance of IND Application for CYAD-101, a First-in-Class Non-Gene Edited Allogeneic CAR-T Candidate

Celyad Announces FDA Acceptance of IND Application for CYAD-101, a First-in-Class Non-Gene Edited Allogeneic CAR-T Candidate

Transparency notification of TOLEFI SA (Article 14 of the Law of 2 May 2007)

Transparency notification of TOLEFI SA (Article 14 of the Law of 2 May 2007)

Notification de transparence - TOLEFI

Notification de transparence - TOLEFI

Information on the total number of voting rights and shares (Articles 15 of the Law of 2 May 2007)

Information on the total number of voting rights and shares (Articles 15 of the Law of 2 May 2007)

Celyad announces closing of global offering

Celyad announces closing of global offering

Celyad announces pricing of $47.3 million global offering

Celyad announces pricing of $47.3 million global offering

Celyad announces launch of proposed global offering

Celyad announces launch of proposed global offering

Celyad Announces First Quarter 2018 Business Update

Celyad Announces First Quarter 2018 Business Update

SEC Filings

SEC Filings

Read more

Events & webcasts

Want to see more?

Events & webcasts